GL1X · GenesisL1 explorer

Research workbench

Kinase domain of csrc in complex with inhibitor RL37 (type III)

Analyse Kinase domain of csrc in complex with inhibitor RL37 (type III) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3F3U
Type
protein
Length
520 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase src
EC
2.7.10.2
UniProt
P00523
Ligands
1AW
Pockets
5 · best druggability 0.76

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein26142% helix, 16% strandP00523
BProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein25940% helix, 17% strandP00523

Ligands and binding sites

  • 1AW · 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea · ligand · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19780.760.78831AW
24110.720.83461AW
33820.590.7640empty
4640.420.8122empty
5870.320.7312empty

Interfaces

1 interface between chains.

  • A–B · 394 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 3F3U · Kinase domain of cSrc in complex with inhibitor RL37 (Type III) · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.